Author

Muneyuki Masuda

National Hospital Organization Kyushu Cancer CenterORCID 0000-0002-7479-8356Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Jorge Silvio GutkindiD· 1 shared Kenichi TaguchiiD· 1 shared Kensuke KoikeiD· 1 shared Koshi MimoriiD· 1 shared Kuniaki SatoiD· 1 shared Mayumi OnoiD· 1 shared Noritaka KomuneiD· 1 shared Shinsaku ItoyamaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Jorge Silvio GutkindORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedJan 12, 2026

Aberrant Hippo-YAP/TEAD signaling drives malignant transcriptional reprogramming in external auditory canal squamous cell carcinoma

Kuniaki Sato, Noritaka Komune, Mayumi Ono…·Takashi Nakagawa

This study identifies hyperactivation of YAP/TEAD signaling in EACSCC and shows that targeting TEAD or PITX2 can suppress tumor growth and predict poor prognosis.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky